(NYSE:SPNT), HAMILTON, Bermuda, Dec. 23, 2025 (GLOBE NEWSWIRE) — SiriusPoint Ltd. (“SiriusPoint” or the “Company”) (NYSE: SPNT), a global specialty insurer and reinsurer, has today announced that International Medical Group (“IMG”), a leader in global insurance benefits and assistance services, and SiriusPoint's wholly owned subsidiary, will acquire Assist America. Founded in 1990, by George W. […]

SiriusPoint announces expansion of IMG services following acquisition of Assist America GlobeNewswire December 23, 2025 HAMILTON, Bermuda, Dec. 23, 2025 (GLOBE NEWSWIRE) — SiriusPoint Ltd. (“SiriusPoint” or the “Company”) (NYSE: SPNT), a global specialty insurer and reinsurer, has today announced that International Medical Group (“IMG”), a leader in global insurance benefits and assistance services, and

(NasdaqGM:MNKD), FDA approves FUROSCIX(R) for use in pediatric patients weighing 43kg or above USPTO issues five patents for FUROSCIX ReadyFlow(TM) Autoinjector WESTLAKE VILLAGE, Calif. and BURLINGTON, Mass., Dec. 23, 2025 (GLOBE NEWSWIRE) — MannKind Corporation (Nasdaq: MNKD) today announced two business updates–approval of the FUROSCIX(R) (furosemide) On-body Infusor for pediatric patients and issuance of additional

(PinkSheets:TGNT),(Pinksheets:TGNT), BOCA RATON, Fla., Dec. 23, 2025 (GLOBE NEWSWIRE) — As the year comes to a close and the holiday season begins, Totaligent, Inc. (OTCID: TGNT)(“Totaligent” or “the Company”), an emerging leader in intelligent business marketing and AI-powered data solutions, today announced the successful completion of quality assurance (“QA”) testing across its entire marketing and

(NASDAQ:BLLN), MENLO PARK, Calif., Dec. 23, 2025 (GLOBE NEWSWIRE) — BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced that Company management will participate in the 44th Annual J.P. Morgan Healthcare Conference. Management will present from 9:45am to 10:25am

(NASDAQ:FRSX),(TASE:FRSX.TA), Ness Ziona, Israel, Dec. 23, 2025 (GLOBE NEWSWIRE) — Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX) (“Foresight” or the “Company”), an innovator in 3D perception systems, announced today entering into a multi-phase strategic cooperation agreement for its 3D perception systems with Zeda Korea Ltd. (“Zeda Korea”), a leading South Korean manufacturer of road

Totaligent Wraps Up 2025 with Completion of Full Marketing Platform, Shares Holiday Message from CEO GlobeNewswire December 23, 2025 BOCA RATON, Fla., Dec. 23, 2025 (GLOBE NEWSWIRE) — As the year comes to a close and the holiday season begins, Totaligent, Inc. (OTCID: TGNT)(“Totaligent” or “the Company”), an emerging leader in intelligent business marketing and

MannKind Shares FUROSCIX(R) Business Updates GlobeNewswire December 23, 2025 FDA approves FUROSCIX(R) for use in pediatric patients weighing 43kg or above USPTO issues five patents for FUROSCIX ReadyFlow(TM) Autoinjector WESTLAKE VILLAGE, Calif. and BURLINGTON, Mass., Dec. 23, 2025 (GLOBE NEWSWIRE) — MannKind Corporation (Nasdaq: MNKD) today announced two business updates–approval of the FUROSCIX(R) (furosemide) On-body

BillionToOne to Participate in the 44th Annual J.P. Morgan Healthcare Conference GlobeNewswire December 23, 2025 MENLO PARK, Calif., Dec. 23, 2025 (GLOBE NEWSWIRE) — BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced that Company management will participate in

Foresight Expands Road Safety Product Outreach in South Korea with a Strategic Cooperation Agreement GlobeNewswire December 23, 2025 Ness Ziona, Israel, Dec. 23, 2025 (GLOBE NEWSWIRE) — Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX) (“Foresight” or the “Company”), an innovator in 3D perception systems, announced today entering into a multi-phase strategic cooperation agreement for